| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
16,495 |
14,910 |
$10.67M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
14,254 |
13,148 |
$6.09M |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
1,951 |
1,643 |
$968K |
| 90832 |
Psychotherapy, 30 minutes with patient |
2,048 |
1,980 |
$626K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,086 |
5,666 |
$351K |
| 90837 |
Psychotherapy, 53 minutes with patient |
102 |
73 |
$16K |
| 90834 |
Psychotherapy, 45 minutes with patient |
301 |
222 |
$8K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
52 |
52 |
$719.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
163 |
160 |
$654.00 |
| 92551 |
|
237 |
237 |
$640.00 |
| 92015 |
Determination of refractive state |
482 |
482 |
$640.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
493 |
457 |
$200.00 |
| 80061 |
Lipid panel |
157 |
157 |
$120.04 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
68 |
67 |
$0.00 |
| 86803 |
|
43 |
42 |
$0.00 |
| 86317 |
|
25 |
25 |
$0.00 |
| 86592 |
|
101 |
100 |
$0.00 |
| 1220F |
|
295 |
289 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
517 |
507 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
171 |
170 |
$0.00 |
| 83051 |
|
116 |
116 |
$0.00 |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
87 |
84 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
157 |
155 |
$0.00 |
| 87428 |
|
63 |
61 |
$0.00 |
| 80050 |
General health panel |
124 |
122 |
$0.00 |
| V2103 |
Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens |
21 |
14 |
$0.00 |
| V2784 |
Lens, polycarbonate or equal, any index, per lens |
62 |
31 |
$0.00 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
25 |
25 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
13 |
13 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
12 |
12 |
$0.00 |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
13 |
13 |
$0.00 |
| V2020 |
Frames, purchases |
138 |
138 |
$0.00 |
| 90863 |
|
766 |
749 |
$0.00 |
| 81025 |
|
54 |
51 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
498 |
472 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
165 |
162 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
25 |
24 |
$0.00 |
| 81003 |
|
139 |
135 |
$0.00 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
30 |
25 |
$0.00 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
28 |
26 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
27 |
24 |
$0.00 |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
13 |
13 |
$0.00 |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
59 |
55 |
$0.00 |
| V2500 |
Contact lens, pmma, spherical, per lens |
31 |
31 |
$0.00 |
| 3016F |
|
103 |
102 |
$0.00 |